PRODUCT
Development Product
TOTAL
| Product Name | Therapeutic Category | Remark |
|---|---|---|
| Mirabegron Amorphous | Overactive Bladder | DMF available |
| Mirabegron Form Alpha | Overactive Bladder | DMF registration |
| Nilotinib HCl | Anti cancer | New crystalline |
| Nintedanib base | Idiopathic pulmonary fibrosis | DMF available, change salt |
| Nintedanib esylate | Idoipathic pulmonary fibrosis | DMF available |
| Nipedipine Oros Tablet | Anti anginal, Anti hypertensive | Can be supplied in the form of imported finished products or BULK |
| Olaparib | PARP inhibitor | Patent Avoidable |
| Osimertinib mesylate | Kinase inhibitor | DMF Available |
| Palbociclib | Kinase inhibitor | Patent Avoidable |
| Pancreatine | Digestive medicine | DMF available |